TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,184,955 | +0.3% | 57,941 | +0.9% | 0.00% | – |
| Q2 2023 | $2,177,751 | +432.5% | 57,415 | +406.6% | 0.00% | – |
| Q2 2022 | $409,000 | -54.9% | 11,334 | -45.9% | 0.00% | – |
| Q1 2022 | $906,000 | -75.0% | 20,937 | -71.0% | 0.00% | -100.0% |
| Q4 2021 | $3,622,000 | -22.6% | 72,281 | -1.8% | 0.00% | 0.0% |
| Q3 2021 | $4,682,000 | -30.6% | 73,573 | -21.5% | 0.00% | 0.0% |
| Q2 2021 | $6,743,000 | -7.4% | 93,710 | -5.1% | 0.00% | 0.0% |
| Q1 2021 | $7,283,000 | -50.0% | 98,756 | -50.3% | 0.00% | -66.7% |
| Q4 2020 | $14,577,000 | +38.8% | 198,539 | +3.7% | 0.00% | +50.0% |
| Q3 2020 | $10,505,000 | +20.9% | 191,512 | +46.5% | 0.00% | 0.0% |
| Q2 2020 | $8,690,000 | +131.9% | 130,698 | +113.4% | 0.00% | +100.0% |
| Q1 2020 | $3,748,000 | -30.6% | 61,259 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $5,402,000 | +23.7% | 61,438 | +6.2% | 0.00% | 0.0% |
| Q3 2019 | $4,367,000 | -3.9% | 57,877 | +8.8% | 0.00% | 0.0% |
| Q2 2019 | $4,545,000 | -21.6% | 53,204 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $5,794,000 | +16.4% | 53,612 | -8.8% | 0.00% | 0.0% |
| Q4 2018 | $4,977,000 | -37.5% | 58,802 | -27.4% | 0.00% | -50.0% |
| Q3 2018 | $7,963,000 | -15.3% | 80,996 | -0.4% | 0.00% | 0.0% |
| Q2 2018 | $9,404,000 | +83.0% | 81,294 | +56.2% | 0.00% | +100.0% |
| Q1 2018 | $5,139,000 | -3.7% | 52,052 | +2.1% | 0.00% | 0.0% |
| Q4 2017 | $5,336,000 | -58.8% | 50,960 | -55.7% | 0.00% | -66.7% |
| Q3 2017 | $12,954,000 | +3.1% | 114,952 | +2.5% | 0.00% | -25.0% |
| Q2 2017 | $12,569,000 | -14.1% | 112,168 | -10.6% | 0.00% | 0.0% |
| Q1 2017 | $14,634,000 | +14.1% | 125,477 | +3.0% | 0.00% | 0.0% |
| Q4 2016 | $12,825,000 | +11.3% | 121,824 | +16.8% | 0.00% | 0.0% |
| Q3 2016 | $11,526,000 | -30.0% | 104,300 | -7.7% | 0.00% | -20.0% |
| Q2 2016 | $16,459,000 | +65.5% | 113,044 | +62.7% | 0.01% | +66.7% |
| Q1 2016 | $9,948,000 | -1.7% | 69,468 | +6.1% | 0.00% | 0.0% |
| Q4 2015 | $10,118,000 | +495.5% | 65,465 | +450.9% | 0.00% | +200.0% |
| Q3 2015 | $1,699,000 | +541.1% | 11,883 | +544.1% | 0.00% | – |
| Q2 2015 | $265,000 | -88.9% | 1,845 | -89.1% | 0.00% | -100.0% |
| Q1 2015 | $2,383,000 | -16.4% | 16,899 | -12.2% | 0.00% | 0.0% |
| Q4 2014 | $2,852,000 | -16.3% | 19,245 | -13.1% | 0.00% | 0.0% |
| Q3 2014 | $3,407,000 | +1215.4% | 22,145 | +1100.3% | 0.00% | – |
| Q2 2014 | $259,000 | – | 1,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |